Song Li, Dianze Chen, Huiqin Guo, Yanan Yang, Dandan Liu, Chunmei Yang, Xing Bai, Wei Zhang, Li Zhang, Gui Zhao, Xiaoping Tu, Liang Peng, Sijin Liu, Yongping Song, Zhongxing Jiang, Ruliang Zhang, Jifeng Yu, Wenzhi Tian. IMM47, a humanized monoclonal antibody that targets CD24, exhibits exceptional anti-tumor efficacy by blocking the CD24/Siglec-10 interaction and can be used as monotherapy or in combination with anti-PD1 antibodies for cancer immunotherapy.Antibody therapeutics. 2023, 6 (4): 240-252
Rashmi Srivastava, Alireza Labani-Motlagh, Apeng Chen, Jose Alejandro Bohorquez, Bin Qin, Meghana Dodda, Fan Yang, Danish Ansari, Sahil Patel, Honglong Ji, Scott Trasti, Yapeng Chao, Yash Patel, Han Zou, Baoli Hu, Guohua Yi. Development of a human glioblastoma model using humanized DRAG mice for immunotherapy.Antibody therapeutics. 2023, 6 (4): 253-264
Dora Buzas, Adrian H Bunzel, Oskar Staufer, Emily J Milodowski, Grace L Edmunds, Joshua C Bufton, Beatriz V Vidana Mateo, Sathish K N Yadav, Kapil Gupta, Charlotte Fletcher, Maia K Williamson, Alexandra Harrison, Ufuk Borucu, Julien Capin, Ore Francis, Georgia Balchin, Sophie Hall, Mirella V Vega, Fabien Durbesson, Srikanth Lingappa, Renaud Vincentelli, Joe Roe, Linda Wooldridge, Rachel Burt, Ross J L Anderson, Adrian J Mulholland, Bristol Uncover Group, Jonathan Hare, Mick Bailey, Andrew D Dav. generated antibodies guide thermostable ADDomer nanoparticle design for nasal vaccination and passive immunization against SARS-CoV-2.Antibody therapeutics. 2023, 6 (4): 277-297
Nathanaël Rakotoarinoro, Yan F K Dyck, Simon K Krebs, Miriam-Kousso Assi, Maria K Parr, Marlitt Stech. A disruptive clickable antibody design for the generation of antibody-drug conjugates.Antibody therapeutics. 2023, 6 (4): 298-310
Shiyong Gong, Chengbin Wu. Efficient production of bispecific antibodies-optimization of transfection strategy leads to high-level stable cell line generation of a Fabs-in-tandem immunoglobin.Antibody therapeutics. 2023, 6 (3): 170-179
Anthony M Deacy, Samuel Ken-En Gan. The influence of variable-heavy chain families on IgG, , , FcγRs and B-cell superantigens protein G and L binding using biolayer interferometry.Antibody therapeutics. 2023, 6 (3): 182-193
Zhouyi Wu, Gangling Xu, Wu He, Chuanfei Yu, Wanqiu Huang, Shirui Zheng, Dian Kang, Michael H Xie, Xingjun Cao, Lan Wang, Kaikun Wei. Comparability strategy and demonstration for post-approval production cell line change of a bevacizumab biosimilar IBI305.Antibody therapeutics. 2023, 6 (3): 194-210
Mariya B Shapiro, Jacqueline Boucher, Anna Brousseau, Amin Dehkharghani, Justin Gabriel, Vishal Kamat, Ketan Patil, Feng Gao, Jennifer Walker, Ryan Kelly, Colby A Souders. Alpaca single B cell interrogation and heavy-chain-only antibody discovery on an optofluidic platform.Antibody therapeutics. 2023, 6 (3): 211-223